Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2014-07-03
Metadata
Show full item recordPublisher
Elsevier B.V.Journal
The LancetDOI
https://doi.org/10.1016/S0140-6736(13)62087-5Additional Links
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2962087-5/fulltextAbstract
We read with interest the Lancet Series on Global Kidney Disease. Valerie Luyckx and colleagues describe the economics and medical management of chronic kidney disease in sub-Saharan Africa.1 We note clear similarities with patients in Peru. Indeed, in Peru, the Ministry of Health (MINSA)—which covers 70% of the population—does not have a comprehensive programme for the management of patients with chronic kidney disease, including renal replacement therapies. However, the Social Security System (Essalud)—which covers 20% of the population—has a chronic kidney disease programme.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessLanguage
engISSN
0140-6736EISSN
1474-547Xae974a485f413a2113503eed53cd6c53
https://doi.org/10.1016/S0140-6736(13)62087-5
Scopus Count
Collections


